Neglected tropical diseases (NTDs), which include leishmaniasis, Chagas disease, human
African trypanosomiasis (HAT), and schistosomiasis, remain public health problems in …

In September 2022, the Drug Discovery Unit at the University of Dundee, UK, organised an
international meeting at the Wellcome Collection in London to explore the current clinical …

Schistosomiasis is a neglected tropical disease affecting more than 200 million people
worldwide. Chemotherapy relies on one single drug, praziquantel, which is safe but …

Schistosomiasis is one of the most important neglected tropical diseases. Until an effective
vaccine is registered for use, the cornerstone of schistosomiasis control remains …

Schistosomiasis is a disease affecting> 200 million people worldwide, but its treatment relies
on a single agent, praziquantel. To investigate new avenues for schistosomiasis control, we …

The present work aimed to carry out in vitro biological assays of thiazole compounds against
adult worms of Schistosoma mansoni, as well as the in silico determination of …

Antimicrobial resistance remains a global issue, hindering the control of bacterial infections.
This study examined the antimicrobial properties of 2, 3‐N, N‐diphenyl quinoxaline …

Schistosomiasis, a parasitic disease caused by infection by helminths of the Schistosoma
genus, affects over 200 million people, primarily in the developing world. Treatment of this …

The human pathogens Plasmodium and Schistosoma are each responsible for over 200
million infections annually, being particularly problematic in low-and middle-income …

Antimalarials play a crucial role in the fight against malaria. However, resistance of the most
virulent malaria parasite, Plasmodium falciparum, to front-line antimalarials is spreading. To …